CA	O
IX	O
and	O
response	O
to	O
PMRT	O

Kaplan	O
-	O
Meier	O
probability	O
plots	O
of	O
OS	O
after	O
PMRT	O
among	O
CA	O
IX	O
positive	O
and	O
CA	O
IX	O
negative	O
patients	O
revealed	O
improved	O
survival	O
after	O
PMRT	O
in	O
both	O
subgroups	O
of	O
patients	O
(	O
Figure	O
2	O
)	O
.	O

Fifteen	O
-	O
year	O
OS	O
probabilities	O
were	O
improved	O
by	O
7	O
%	O
and	O
9	O
%	O
after	O
PMRT	O
for	O
the	O
subgroups	O
of	O
CA	O
IX	O
positive	O
and	O
CA	O
IX	O
negative	O
patients	O
,	O
respectively	O
.	O

The	O
HR	O
of	O
overall	O
mortality	O
after	O
PMRT	O
was	O
0	O
.	O
87	O
(	O
95	O
%	O
CI	O
0	O
.	O
60	O
to	O
1	O
.	O
27	O
)	O
for	O
the	O
small	O
subgroup	O
of	O
151	O
CA	O
IX	O
positive	O
patients	O
and	O
0	O
.	O
82	O
(	O
95	O
%	O
CI	O
0	O
.	O
69	O
to	O
0	O
.	O
97	O
)	O
for	O
the	O
large	O
subgroup	O
of	O
813	O
CA	O
IX	O
negative	O
patients	O
.	O

HRs	O
and	O
95	O
%	O
CIs	O
after	O
PMRT	O
did	O
not	O
differ	O
significantly	O
between	O
CA	O
IX	O
positive	O
and	O
CA	O
IX	O
negative	O
patients	O
for	O
OS	O
,	O
DSS	O
,	O
DM	O
,	O
or	O
LRR	O
(	O
Table	O
4	O
)	O
.	O

In	O
multivariate	O
analysis	O
by	O
Cox	O
regression	O
,	O
no	O
significant	O
interaction	O
was	O
found	O
between	O
CA	O
IX	O
and	O
randomization	O
status	O
for	O
any	O
of	O
the	O
four	O
end	O
-	O
points	O
.	O

Similar	O
tendencies	O
were	O
observed	O
when	O
the	O
women	O
were	O
separated	O
into	O
premenopausal	O
and	O
postmenopausal	O
women	O
,	O
and	O
into	O
women	O
with	O
one	O
to	O
three	O
positive	O
nodes	B-Multi-tissue_structure
and	O
those	O
with	O
more	O
than	O
three	O
positive	O
nodes	B-Multi-tissue_structure
.	O

Table	O
4	O

Hazard	O
ratios	O

CA	O
IX	O
positive	O
(	O
n	O
=	O
151	O
)	O
CA	O
IX	O
negative	O
(	O
n	O
=	O
794	O
)	O

Overall	O
mortality	O
0	O
.	O
87	O
(	O
0	O
.	O
60	O
-	O
1	O
.	O
27	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
69	O
-	O
0	O
.	O
97	O
)	O

Disease	O
-	O
specific	O
mortality	O
0	O
.	O
83	O
(	O
0	O
.	O
55	O
-	O
1	O
.	O
27	O
)	O
0	O
.	O
76	O
(	O
0	O
.	O
63	O
-	O
0	O
.	O
93	O
)	O

Distant	O
metastases	B-Cancer
0	O
.	O
83	O
(	O
0	O
.	O
54	O
-	O
1	O
.	O
25	O
)	O
0	O
.	O
76	O
(	O
0	O
.	O
63	O
-	O
0	O
.	O
91	O
)	O

Locoregional	O
recurrence	O
0	O
.	O
23	O
(	O
0	O
.	O
08	O
-	O
0	O
.	O
61	O
)	O
0	O
.	O
16	O
(	O
0	O
.	O
09	O
-	O
0	O
.	O
28	O
)	O

Presented	O
are	O
hazard	O
ratios	O
(	O
95	O
%	O
confidence	O
intervals	O
)	O
of	O
overall	O
mortality	O
,	O
disease	O
-	O
specific	O
mortality	O
,	O
distant	O
metastases	B-Cancer
and	O
loco	O
-	O
regional	O
recurrence	O
probabilities	O
after	O
postmastectomy	O
radiotherapy	O
in	O
carbonic	O
anhydrase	O
(	O
CA	O
)	O
IX	O
positive	O
and	O
in	O
CA	O
IX	O
negative	O
high	O
-	O
risk	O
breast	B-Cancer
cancer	I-Cancer
patients	O
.	O

Figure	O
2	O

Overall	O
survival	O
in	O
high	O
-	O
risk	O
breast	B-Cancer
cancer	I-Cancer
patients	O
.	O

Shown	O
are	O
Kaplan	O
-	O
Meier	O
probability	O
plots	O
of	O
overall	O
survival	O
in	O
high	O
-	O
risk	O
breast	B-Cancer
cancer	I-Cancer
patients	O
as	O
a	O
function	O
of	O
randomization	O
to	O
postmastectomy	O
radiotherapy	O
(	O
RT	O
)	O
within	O
the	O
subgroups	O
of	O
carbonic	O
anhydrase	O
(	O
CA	O
)	O
IX	O
negative	O
and	O
CA	O
IX	O
positive	O
patients	O
.	O

The	O
values	O
given	O
in	O
parentheses	O
after	O
hazard	O
ratios	O
(	O
HRs	O
)	O
are	O
the	O
95	O
%	O
confidence	O
intervals	O
.	O

Changing	O
the	O
cutpoints	O
to	O
at	O
least	O
one	O
tumour	B-Cell
cell	I-Cell
,	O
or	O
>	O
=	O
20	O
%	O
or	O
>	O
=	O
30	O
%	O
invasive	B-Cancer
tumour	I-Cancer
staining	O
did	O
not	O
improve	O
the	O
predictive	O
value	O
of	O
positive	O
CA	O
IX	O
staining	O
(	O
data	O
not	O
presented	O
)	O
.	O

